
Prescription required
Reviewed by:
Prescription required
Naltrexone hydrochloride is an oral, synthetic prescription medication classified as a pure opioid receptor antagonist, designed to block the reinforcing neurochemical pathways associated with substance dependence. It is indicated for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence following complete detoxification. By binding to central nervous system opioid receptors, naltrexone completely neutralizes the euphoria and psychological reinforcement typically induced by alcohol and narcotics, without inducing physical dependence or abuse potential. It is most clinically effective when deployed as a core component of a comprehensive behavioral modification and counseling program.
Ready to Fill
Naltrexone
Revia
Opioid antagonist; medication used for alcohol use disorder and opioid dependence maintenance treatment
No
Oral tablets
Basics
Naltrexone hydrochloride is an oral, synthetic prescription medication classified as a pure opioid receptor antagonist. It functions as a specialized pharmacological modulator designed to block the reinforcing neurochemical pathways associated with substance dependence.
Clinically, naltrexone tablets are indicated for the:
By target-locking central nervous system opioid receptors, naltrexone completely neutralizes the euphoria, physical reward, and psychological reinforcement typically induced by alcohol and narcotics. Because it acts as a pure antagonist with zero intrinsic narcotic activity, it does not induce physical dependence or serve as a vehicle for structural abuse. It is most clinically effective when deployed as a core component of a comprehensive behavioral modification and counseling program.
Indications
Naltrexone is indicated for the treatment of alcohol dependence and for the prevention of relapse to opioid dependence following complete detoxification from all exogenous opioids.
Mechanism
Pharmacodynamics and Reward Circuit Interception
The psychological and physical reinforcement driving substance dependence relies heavily on the mesolimbic dopamine system — the primary reward pathway of the brain. Naltrexone intervenes directly within this circuit by acting as a highly potent, competitive pure opioid antagonist with its highest binding affinity concentrated at the μ (mu) and κ (kappa) opioid receptors.
Pharmacokinetics
Dosage
Standard Clinical Dosing Protocols
Strict Treatment Inception Prerequisites
The Absolute Opioid-Free Detoxification Threshold
Naltrexone must never be initiated in a patient who has not achieved complete, absolute detoxification from all exogenous opioids for a minimum duration of 7 to 10 consecutive days. Before administering the first tablet, an immediate naloxone challenge test or a strict urine toxicology screening must be executed to confirm zero residual narcotic presence. If naltrexone is introduced into an individual with circulating opioids in their system, its high affinity will instantly dislodge the narcotics, precipitating an immediate, violent, and life-threatening Acute Precipitated Opioid Withdrawal Syndrome requiring emergency hospitalization.
Administration Handling: Tablets can be taken with or without food. Ingesting the daily dose with a meal or a large glass of milk is highly recommended during the initial week of care to minimize the risk of local enteric receptors triggering transient nausea.
Why pay retail prices for the same medication?
At Invictus, we source directly from trusted, FDA-approved manufacturers to keep your costs low without sacrificing quality. Whether you need a one-time fill or regular refills, our transparent pricing makes it easy to save every day.
Side Effects
Dose-Dependent Hepatotoxicity
During initial high-dose clinical evaluations, naltrexone demonstrated a capacity to induce hepatocellular injury:
The Emergency Opioid Overdose Hazard
Patients must be explicitly warned about a critical, life-threatening vulnerability that can manifest following a period of continuous naltrexone therapy:
Precipitation of Severe Depression and Suicidal Ideation
Patients navigating substance recovery pathways exhibit a high baseline prevalence of comorbid mood disorders. Naltrexone has been linked to emerging or worsening depression, severe generalized anxiety, and suicidal ideation in vulnerable individuals. Monitor all recovering patients closely for sudden behavioral shifts or thoughts of self-harm.
Common Adverse Reactions
The most frequent side effects documented across large-scale recovery registries are typically mild, self-limiting, and concentrate within the first 1 to 2 weeks of starting therapy:
Interactions
Contraindications
Additional Considerations
Pregnancy and Neonatal Coordination
Data on the use of oral naltrexone tablets in pregnant individuals are limited. Animal reproductive models with highly elevated maternal exposures showed minor embryocidal effects but no structural teratogenic malformations. Untreated alcohol or opioid dependence during gestation is a high-stakes hazard linked to fetal alcohol syndrome, placental abruption, and low birth weight. Naltrexone should be deployed during pregnancy only if the potential recovery benefits to the mother strictly justify the unknown risks to the developing fetus.
Lactation
Both naltrexone and its active 6-β-naltrexol metabolite are excreted into human breast milk in low quantities. Because data regarding long-term infant exposure are sparse, a careful clinical risk-benefit assessment must be conducted. If maternal therapy is mandatory, the nursing infant must be monitored closely for excessive sedation, poor feeding, or changes in developmental milestones.
Geriatric Care
Naltrexone is rarely deployed as a primary intervention within elderly demographics. Geriatric individuals exhibit a significantly higher prevalence of baseline age-related chronic liver decline and advanced multi-system medication regimens. If use is deemed necessary, a comprehensive liver function panel must be confirmed at baseline, paired with enhanced physical tracking for early signs of cognitive or gastrointestinal changes.
The information provided on this page is for general informational purposes only and is not intended as medical advice. Always consult with a licensed healthcare provider before starting, stopping, or changing any medication regimen. While Invictus strives to provide accurate and up-to-date information, individual health conditions and circumstances vary. The prices, availability, and descriptions of all medications on this page are subject to change.
Your Prescription
Ready to Fill